The WHO has supported the use of Merck’s antiviral tablets against COVID-19. The panel recommended the molnupiravir tablet for at-risk and unvaccinated patients.

4gi.tv
The WHO has supported the use of Merck’s antiviral tablets against COVID-19. The panel recommended the molnupiravir tablet for at-risk and unvaccinated patients.
Copyright © 2022. All Rights Reserved.